Le Ridant A M, Guyot S, Grittli S, Marandas P, de Baere T, Julieron M, Schwaab G, Luboinski B
Département de Chirurgie Cervico-Faciale et ORL, Institut Gustave Roussy, Villejuif.
Ann Otolaryngol Chir Cervicofac. 1996;113(3):170-4.
We report a series of 174 percutaneous gastrostomies implanted in our interventional radiology unit in patients with cancer of the upper airway and upper digestive tract: two localizations, hypopharynx and oropharynx comprised 68% of the cases (106/174). Tumor stage had reached palliative treatment in 80 cases, was in the initial phase of treatment in 57 cases and was in a sequelae phase after treatment in 37 cases. Despite problems related to anatomic modifications and tumor volume or sequelae of prior or ongoing treatment, we did not record any failures. The rate of minor complications was 15%. The one severe complication (peritonitis) required laparotomy. The duration of enteral nutrition via the gastrostomy varied from 3 weeks to more than 3 years. There were no long-term complications. We thus suggest that interventional percutaneous gastrostomy is a useful alternative to endoscopic percutaneous gastrostomy or the nasoesophageal tube, particularly in patients with voluminous tumors restricting the hypopharynx and oropharynx.
我们报告了在我们介入放射科为上呼吸道和上消化道癌症患者植入的174例经皮胃造瘘术：两个部位，下咽和口咽占病例的68%（106/174）。80例患者肿瘤分期已达姑息治疗阶段，57例处于治疗初期，37例处于治疗后后遗症阶段。尽管存在与解剖结构改变、肿瘤体积或既往或正在进行的治疗后遗症相关的问题，但我们未记录到任何失败情况。轻微并发症发生率为15%。1例严重并发症（腹膜炎）需要开腹手术。经胃造瘘术进行肠内营养的持续时间从3周至3年以上不等。无长期并发症。因此，我们认为介入性经皮胃造瘘术是内镜下经皮胃造瘘术或鼻饲管的一种有用替代方法，特别是对于肿瘤体积较大限制下咽和口咽的患者。
